![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 22, 17100-17105, June 2, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
andFrom the Biochemisches Institut, Universität Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland
Received for publication, December 23, 1999, and in revised form, March 8, 2000
| |
ABSTRACT |
|---|
|
|
|---|
The production of recombinant proteins in the
periplasm of Escherichia coli can be limited by folding
problems, leading to periplasmic aggregates. We used a selection system
for periplasmic chaperones based on the coexpression of an E. coli library with a poorly expressing antibody single-chain Fv
(scFv) fragment displayed on filamentous phage (Bothmann, H., and
Plückthun, A. (1998) Nature Biotechnol. 16, 376-380). By selection for a functional antibody, the protein Skp had
been enriched previously and shown to improve periplasmic expression of
a wide range of scFv fragments. This selection strategy was now
repeated with a library constructed from the genomic DNA of an
skp-deficient strain, leading to enrichment of the
periplasmic peptidylprolyl cis,trans-isomerase (PPIase) FkpA. Coexpression of FkpA increased the amount of fusion protein displayed on the phage and dramatically improved functional periplasmic expression even of scFv fragments not containing
cis-prolines. In contrast, the coexpression of the
periplasmic PPIases PpiA and SurA showed no increase in the functional
scFv fragment level in the periplasm or displayed on phage. Together
with the in vitro data in the accompanying paper (Ramm, K.,
and Plückthun, A. (2000) J. Biol. Chem. 275, 17106-17113), we conclude that the effect of FkpA is independent of
its PPIase activity.
An important strategy for the production of recombinant
disulfide-containing proteins is their secretion to the periplasmic space of Escherichia coli, as the periplasm is the location
of the disulfide-forming machinery (1, 2). Antibodies are one class of
particularly important disulfide-containing proteins that have
frequently been expressed in this compartment, and this is probably the
most convenient method to obtain engineered antibodies for research and
medical or technological applications (3-5). Unfortunately, folding
problems of antibodies and other heterologous proteins in the
periplasm are frequently observed, and the nature and existence of
molecular chaperones in this compartment are still only poorly
understood (2, 6, 7).
It has been previously shown (8-12) that the functional periplasmic
expression of antibody fragments can be limited by the sequence-dependent, moderate efficiency of periplasmic
folding, which can furthermore be accompanied by cell lysis, as has
also been observed for other proteins (13). Typically, the actual membrane transport is not limiting (8), and large amounts of correctly
processed, but precipitated protein are available in the periplasm. It
is still unclear which factors, if any, might play a role in preventing
the aggregation and in guiding the correct folding of functional
antibody fragments or other periplasmic proteins in E. coli,
and it is certainly conceivable that different factors play a role for
different proteins.
We have recently developed a selection system for the identification of
novel factors that may help the functional periplasmic expression of a
substrate protein in question (14). It was based on the assumption that
the folding of soluble periplasmic protein occurs in contact with the
same machinery and in the same environment as that of a protein
displayed on filamentous phage. Fusion proteins with the minor coat
protein gene-3 protein (g3p)1
of filamentous phage are transiently produced in a state anchored to
the inner membrane, before they are incorporated into the phage coat
(15). Thus, the folding of the fusion protein occurs in the periplasm
and should be influenced by the same factors as that of a soluble
periplasmic protein.
The selection system works by displaying a poorly expressing antibody
fragment on filamentous phage and coexpressing a library of E. coli genes on the same phagemid. Note that these E. coli proteins encoded by the library are not displayed; they are
merely expressed by the host cell producing a particular phage in
question. If the coexpressed factor improves expression of the
antibody-g3p fusion protein, a higher percentage of the phage particles
will carry a functional antibody fragment and thus be selectable, even though this displayed antibody fragment is identical in all cases.
In a previous study, we identified the periplasmic protein Skp (OmpH,
HlpA) by this methodology (14). Since we wanted to select for
additional factors that might increase the expression yield, we have
repeated this selection in the present study, this time using an
E. coli library prepared from a strain devoid of the
skp gene. We enriched the gene coding for the protein FkpA, a periplasmic peptidylprolyl cis,trans-isomerase (16). Upon characterizing the effect further, we found that only FkpA, but not the
other periplasmic peptidylprolyl cis,trans-isomerases PpiA
and SurA, had any such effect, suggesting that there is no functional
redundancy in these enzymes. Most intriguingly, we found that FkpA has
also a very beneficial effect on antibody fragments whose rate-limiting
proline isomerization it cannot catalyze and, particularly noteworthy,
that do not have any cis-proline at all.
Construction of Genomic Library--
The gel-purified
SfiI fragment encoding the scFv fragment of the anti-levan
antibody ABPC48-C(H22)S (17, 18) was ligated into the phage display
vector pHB100 (14), yielding plasmid pHB121. The genomic DNA of the
skp-deficient E. coli strain RC354c (19) was
isolated with a Nucleobond AXG100 cartridge (Macherey Nagel) according
to the manufacturer's protocol. The genomic DNA was partially digested
with Sau3AI and applied to a 1% agarose gel. A range of
fragment sizes from 1 to 6 kb in length was cut out, and the genomic
DNA was eluted with GenEluteTM agarose spin columns
(Supelco Inc.), phenol/chloroform-extracted, and ethanol-precipitated.
After ligation of the E. coli library into the
BglII site of the polylinker of pHB121, the ligation mixture
was precipitated with 1-butanol and electroporated into E. coli XL1-Blue (Stratagene). After plating on 2× YT in
530-cm2 dishes (Nunc) and overnight incubation at 37 °C,
the colonies were washed off the plates with 5 ml of 2× YT;
OD550 was determined; and the cells were stored at
Phage Panning--
Phage panning was carried out as described
(14). For enriching the levan-binding scFv fragment, immunotubes (Nunc)
were coated with 10 µg/ml levan (polyfructose; Sigma) in
phosphate-buffered saline (8 mM
Na2HPO4, 1.8 mM
KH2PO4, 137 mM NaCl, and 3 mM KCl, pH 7.4) overnight at 4 °C, and for enriching
anti-fluorescein antibodies, with 20 mg/ml fluorescein isothiocyanate
coupled to bovine serum albumin in phosphate-buffered saline and
blocked with 5% skim milk in phosphate-buffered saline containing
0.05% Tween 20 for at least 1 h at room temperature.
Phage Purification and ELISA--
Phage purification and ELISA
were carried out exactly as described (14).
Western Blots--
To compare the in vivo folding
properties of the scFv fragments with and without coexpressed factors,
the ratio of soluble to insoluble material that had accumulated in the
periplasm during expression was determined. A 50-ml volume of LB medium
containing 30 µg/ml chloramphenicol was inoculated to
OD550 = 0.1 with an overnight culture, grown at 37 °C
from a single colony of E. coli JM83, harboring a plasmid
encoding the respective antibody fragment. The cultures were grown at
24 or 37 °C and induced with 1 mM
isopropyl- Crude Extract ELISA--
Preparation of E. coli
extracts and ELISA were carried out as described (14). For cultures
grown at 37 °C, the cells were harvested 3 h after induction.
Phage Selection and Identification of Coexpressed Factors--
We
used a phagemid displaying the poorly folding scFv fragment of the
anti-levan antibody ABPC48-C(H22)S as the recipient for an E. coli genomic library. The genomic DNA of E. coli
RC354c, an skp-deficient strain (19), was size-fractionated
from 1 to 6 kb and ligated into the polylinker of plasmid pHB121 (see
"Experimental Procedures"). Thus, E. coli genes,
regulated under their own promoters, are overexpressed on the phagemid,
primarily through an effect of vector copy number. A library size of
6.4 × 105 clones ensured that each piece of the
E. coli genome should be represented, provided it led to
viable clones.
Seven panning rounds on levan were carried out, and phagemid DNA from
each round was cut with the restriction enzyme NotI to
detect the accumulation of any inserts. It can be seen in Fig. 1 that two bands of ~1.7 and 2.0 kb
accumulated throughout the panning. Fourteen of 17 single colonies
analyzed after the seventh round carried the 1.7-kb insert, and three
carried the 2.0-kb insert. Both inserts were sequenced (1629 and 1987 bp, respectively) and were found to contain the same two complete genes
coding for the periplasmic protein FkpA (Fig.
2) (16, 21) and the open reading frame
SlyX with unknown function. Both fragments end 218 bp after the stop
codon of fkpA. Therefore, both inserts also contain the
first 21 amino acids of the gene yheO (Swiss-Prot accession
number P45533), which codes for a protein with unknown function and
strong similarity to Hemophilus influenzae HI0575. The
1629-bp insert continues for 159 bp downstream of the stop codon of
slyX, whereas the 1987-bp insert continues for 528 bp
downstream of the stop codon of slyX. Both inserts therefore also contain the C-terminal part of slyD (WHP) (22-25). The
1987-bp insert also contains the first 117 amino acids of YheP, an open reading frame with unknown function or significance.
The panning procedure was also carried out with the fluorescein-binding
scFv fragment 4-4-20 (26-28) on FITC-bovine serum albumin. The library
size was 6.9 × 105, and 5 of 10 single colonies
analyzed after the seventh panning round showed the same 2.0-kb insert
as enriched with the anti-levan antibody (data not shown). One clone
showed a 1.8-kb insert. This band was sequenced and contained a 1650-bp
insert, starting 120 bp downstream of the stop codon of slyX
and ending 278 bp downstream of the stop codon of fkpA (Fig.
2).
To examine which of the two complete genes present on the fragments,
obtained by panning with two different antibodies, is responsible for
the enrichment, fkpA and slyX were PCR-amplified and recloned separately as well as together at the same position in
vectors pHB102 and pHB121, which display the FITC-bovine serum albumin-binding scFv fragment 4-4-20 and the levan-binding scFv fragment ABPC48-C(H22)S, respectively (14). The fkpA gene
was PCR-amplified from the translation start site of slyX to
the stop codon of fkpA (Fig. 2) to ensure that it contains
the whole fkpA upstream region. Conversely, the
slyX gene was amplified between the translation start site
of fkpA and the stop codon of slyX for the same
reason. The DNA fragment containing both genes was PCR-amplified
between the stop codons of fkpA and slyX. The PCR primers contained NotI sites at their ends, and the
fragments were cloned in the corresponding site in pHB102 and pHB121.
Characterization of the Influence of FkpA and SlyX on Phage Display
and Soluble Expression--
For examination of the possible effects of
FkpA on the yield of periplasmically expressed proteins, several
different scFv fragments were chosen as test molecules for the
following reasons. The 4-4-20 scFv fragment (27) and the ABPC48-C(H22)S
scFv fragment (17, 18) show rather poor folding properties as compared
with the well expressed FITC-E2 scFv fragment (29, 30). The scFv fragment McPC603-H11 (10) has been a model system in previous studies
(9, 10) and can be easily quantitated on a large scale. The
disulfide-free hu4D5-8 scFv fragment (abbreviated
4D5
To determine how and why FkpA, or possibly SlyX, became enriched, we
characterized the phage produced in the absence and presence of
coexpressed FkpA and/or SlyX. The antigen-binding phage ELISA (Fig.
3a) showed that overexpression
of FkpA significantly increased the number of functional antibody
molecules on the phage in the case of scFv fragment 4-4-20 compared
with the control phage not overexpressing an additional factor and with
those that overexpress Skp. In contrast, the overexpression of SlyX had
no effect on the number of functional antibody molecules on the phage.
Skp and FkpA expressed together had only a very slightly higher effect than FkpA alone.
For scFv fragment ABPC48-C(H22)S (Fig. 3b), the influence of
FkpA was somewhat smaller compared with that of Skp. Again, no influence of SlyX could be detected. The coexpression of FkpA and Skp
had no significant additional benefit compared with FkpA alone. In the
case of the well produced antibody FITC-E2 (Fig. 3c), the
coexpression of FkpA also had no significant effect on the ELISA
signal, whereas the coexpression of SkpA resulted in somewhat more
functional scFv fragment displayed on phage.
We then determined whether the beneficial effect on phage ELISA,
indicating functional scFv-g3p fusion protein, is also reflected in the
total amount of fusion protein per phage. For this purpose, we analyzed
by Western blotting the amount of full-length fusion protein on
CsCl-purified phage particles in the presence and absence of
fkpA and slyX on the phagemid using the
monoclonal antibody 10C3 (37), which recognizes the C-terminal domain
of g3p (Fig. 3, d and e). For scFv fragment
4-4-20, the coexpression of FkpA dramatically increased the amount of
fusion protein on the phage. This effect was higher than for the
coexpression of Skp, whereas the coexpression of both genes led to a
small further increase in incorporated fusion protein. A positive
effect of the coexpression of SlyX was not detectable. For scFv
fragments ABPC48-C(H22)S, FITC-E2, and McPC603-H11 (Fig. 3,
d and e), the coexpression of FkpA had a positive
effect compared with the absence of coexpression, but the benefit was
significantly smaller than the coexpression of Skp for scFv fragments
ABPC48-C(H22)S and FITC-E2. For McPC603-H11, the influence of Skp and
FkpA was about equal.
We then examined the effect of FkpA on the soluble periplasmic
expression of the disulfide-free scFv 4D5 Coexpression of PpiA and SurA--
Since out of three soluble
peptidylprolyl cis,trans-isomerases in the periplasm (PpiA,
SurA, and FkpA), only FkpA became enriched during the panning
procedure, we wanted to investigate the possible influence of PpiA and
SurA in our model system. Furthermore, we were interested to determine
if the expression of the putative folding catalysts FkpA, PpiA, and
SurA is induced by the expression and subsequent accumulation of poorly
folding scFv fragments, as periplasmic folding problems may turn on a
stress response (see below). We thus PCR-cloned PpiA and SurA with
their own promoters and inserted them at the same position as FkpA in
the vector pHB102. We then examined the effect of FkpA, PpiA, and SurA
on the production of the 4-4-20 scFv fragment in soluble form using the
nonsuppressor strain JM83 at 24 °C (Fig.
5a). The amount of soluble
scFv fragment 4-4-20 was dramatically increased in the presence of
overexpressed FkpA compared with its absence. In contrast, the
coexpression of PpiA and SurA showed no improvement of soluble
material. Western blots of the soluble and insoluble proteins of the
scFv fragments confirm these results (Fig. 5b).
The overexpression of FkpA and PpiA was tested by Western blotting with
the aid of a recombinant anti-His tag antibody (38), as they had been
PCR-cloned with a histidine tag (data not shown). We saw no significant
difference in the expression levels of FkpA and PpiA whether the scFv
fragment was induced or not. Since SurA could not be detected by
Western blotting, we conclude that its expression level is much lower
than those of FkpA and PpiA under these conditions (data not shown).
To overcome possible regulatory effects, we also cloned the three genes
fkpA, ppiA, and surA each separately
in a direct operon fusion behind scFv fragments 4-4-20 and
ABPC48-C(H22)S. Therefore, they were expressed together with the scFv
fragment by induction with
isopropyl- Influence of FkpA on in Vivo Expression of an scFv Fragment Missing
cis-Prolines--
To further characterize the function of FkpA, we
studied the anti-GCN4 scFv fragment with the destabilizing mutation
H-R66K (33). This scFv fragment carries a murine
We examined the effect of FkpA on the soluble periplasmic production of
the anti-GCN4 scFv fragment at 37 °C. A significant influence of
coexpressed FkpA could be observed. The amount of soluble material in
crude extract ELISA and Western blotting was significantly increased
(Fig. 4, b and d), even though there was no need
for a PPIase function on this scFv fragment to reach a functional state.
In this work, we validated our selection system for periplasmic
folding factors. They may be extremely useful in increasing the
functional yield of recombinant proteins such as antibodies, which need
to be produced in the periplasm because of their disulfide bonds. We
believe that this selection approach is very promising for the
identification of additional factors involved in periplasmic folding
and in preventing misfolding and that this strategy can be expanded to
the screening of different genetic libraries for such factors. The
protein FkpA, which we have enriched, indeed clearly improves the
expression yield of a wide range of functional scFv fragments in the
periplasm of E. coli (in some cases, 10-fold). This greatly
beneficial effect on the folding yield is visible for all scFv
fragments tested, except one, which has good folding properties anyway.
FkpA was first described as an E. coli protein homologous to
the eukaryotic FK506-binding proteins (FKBPs) (16), a class of well
characterized PPIases that have been shown to be inhibitable by the
macrolide FK506. Mature FkpA is located in the periplasm (21), and its
gene carries Antibody Folding and Effect of FkpA--
The in vitro
folding of antibody scFv fragments containing
FkpA has been independently selected on two occasions with different
antibodies. It is remarkable that it also dramatically improves the
folding of an antibody whose rate-limiting step it cannot catalyze
in vitro (4D5
A "chaperone-like" activity of PPIases has been discussed
controversially before (43-45). The debate was fueled by the fact that
the model system used, human carbonic anhydrase II, still contains two
cis-prolines, requiring complicated analyses. Experiments with citrate synthase as substrate showed that FKBP52 possesses chaperone activity independently of its PPIase activity (46). Additionally, cyclophilin Cyp-40 shows chaperone activity on denatured Function and Regulation of FkpA--
In E. coli, all
periplasmic activities of FkpA, PpiA, SurA, and PpiD have been
individually deleted, and the cells remained viable, also in the double
mutants surA/rotA and fkpA/rotA (21, 48, 49).
Nevertheless, based on the effects seen with surA mutants,
SurA has been proposed to be involved in outer membrane protein
localization and folding (50, 51), as has PpiD (49). Interestingly, the
surA/ppiD double mutant causes lethality, whereas the
surA null mutant can be combined with ppiA,
fkpA, or even an skp null mutant. No particular
substrate protein has been proposed yet for PpiA or FkpA.
Although the deletion of FkpA is not lethal, it leads to increased
Our experiments do not suggest that the physiological role of FkpA for
E. coli periplasmic proteins is independent of its PPIase
activity, which it unequivocally has (35). On the other hand, the
repeated enrichment of FkpA in independent phage panning experiments
shows the strong benefit of FkpA overexpression, which is more
strikingly verified with model proteins not containing cis-prolines. Were the effect "unspecific," a wide
variety of proteins should be able to improve antibody expression when
overexpressed. This is, however, not the case.
It would be plausible to propose that the peptide-binding site of FkpA
may be used to reversibly bind part of the antibody. Whether FkpA acts
as a "protein buffer" (52); binds early in the pathway like the
trigger factor, which is a ribosome-bound FKBP (53-55); rescues
proteins that have denatured from the native state (56); or does even
all of the above remains the subject of further studies.
Multiple Functions of PPIases--
The dual biological role of
these classes of proteins, which, on the one hand, are able to catalyze
the isomerization of a peptide bond and, on the other hand, are
involved in signal transduction at least in some cells (57-61), has
never been fully resolved. Particularly, it has remained mysterious why
so many apparently redundant activities are present in most genomes.
Moreover, attempts to delete one or several of these enzymes have
rarely led to obvious phenotypic effects. In addition to the
experiments performed with the deletion of the E. coli genes
(see above), all 12 cyclophilin and FKBP genes of yeast, identified
with the knowledge of the complete genome sequence, have been deleted,
but the cells were still viable (62), whereas the deletion of the only
parvulin homologue in yeast, ESS1, is lethal (63, 64).
Similarly, two out of four PPIases have been deleted from
Bacillus subtilis, with no phenotypic consequence in rich
medium or under several stress conditions tested. The double mutant
showed a strongly retarded growth behavior only in the absence of all
amino acids except tryptophan and phenylalanine (65). In Erwinia
chrysanthemi, disruption of rotA caused no change in
cell morphology, cell viability, growth rate, or stability of the
extracellular and periplasmic proteins (66). It is certainly possible
that a subset of PPIases fulfills a more general binding function,
which can be exploited to improve folding.
Conclusions--
Taking all the facts together, we conclude that
the beneficial effect of FkpA overexpression must be independent of
proline cis,trans-isomerase activity. First, the effect is
found only with FkpA, but not with PpiA or SurA; and second, it is
found also with a model protein devoid of any cis-prolines.
Additionally, a very strong effect is found with a protein
(4D5
Our results have also validated the selection strategy that uses phage
display of a poorly expressible protein. It is likely that this
approach can be repeated, even with libraries of genes from organisms
other than E. coli. Finally, the overexpression of FkpA
helps to solve a long-standing practical problem in antibody engineering by improving the expression of a wide variety of different antibodies tested.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
80 °C after addition of glycerol to 50% final concentration.
-D-thiogalactopyranoside at OD550 = 0.5. After 3 h of induction at 37 °C or overnight induction at 24 °C, the cells were harvested and resuspended in 4 ml of phosphate-buffered saline. Whole cell extracts were prepared by French
press lysis at 10,000 p.s.i., and 1 ml of the crude extract was
centrifuged in an Eppendorf tube for 30 min at 50,000 rpm in a
TLA-100.3 rotor (Beckman Instruments) at 4 °C. After centrifugation, the supernatants contained the soluble material. The pellets were dissolved in urea-containing buffer as described previously (10). Both
fractions were normalized according to the OD550 and
analyzed by reducing SDS-polyacrylamide gel electrophoresis with
subsequent Western blotting on a nitrocellulose membrane.
Immunostaining was performed with the anti-FLAG antibody M1 (Eastman
Kodak Co.) as the primary antibody (20) and an Fc-specific anti-mouse
antiserum conjugated to horseradish peroxidase (Pierce) as the
secondary antibody. For chemiluminescent detection, the SuperSignal kit (Pierce) was used.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (77K):
[in a new window]
Fig. 1.
Analysis of phagemid pools after different
panning rounds. The phagemid pools were analyzed by restriction
enzyme digest with NotI. Lanes M,
PstI-digested
-DNA as molecular weight marker; lane
0, phagemids before first panning round; lanes 1-7,
panning rounds from which phagemids were isolated.

View larger version (14K):
[in a new window]
Fig. 2.
Schematic representation of the 1629-, 1650-, and 1987-bp fragments enriched by phage display and phage panning.
YheO is the putative product of an open reading frame with unknown
function, but with strong similarity to H. influenzae
HI0575. fkpA and slyD code for peptidylprolyl
cis,trans-isomerases; slyX and yheP
code for proteins with unknown function. Arrows indicate
orientation of the open reading frames. aa, amino
acids.
, to indicate the missing disulfide bonds) (31) is
thermodynamically unstable. Finally, the anti-GCN4 scFv fragment
carries a
-chain (32) and thus no cis-prolines, and a
destabilized variant with the H-R66K mutation was chosen (33) where H
refers to the heavy chain, to observe a possible improvement in
folding. Furthermore, the folding of the last three antibodies has been
characterized in vitro (34-36).

View larger version (40K):
[in a new window]
Fig. 3.
a-c, antigen-binding ELISAs of phages
grown with or without overexpressed Skp, FkpA, SlyX, and combinations
of them, displaying scFv fragments 4-4-20 (27), ABPC48-C(H22)S (17,
18), and FITC-E2 (29, 30), respectively. Phages were purified by CsCl
gradients. d and e, phage blots. Phage carrying
fusions of the scFv fragments to the C-terminal domain (CT)
of g3p of the antibodies indicated were grown with or without
overexpression of Skp, FkpA, SlyX, and combinations of them. Phages
were purified by CsCl gradients. Helper phage VCS M13 was used as size
reference for wild-type (w.t.) g3p. Since the scFv fragment
is fused to the C-terminal domain of g3p, it runs below wild-type g3p
on SDS-polyacrylamide gel. The blot was developed with antibody 10C3
(37). The different scFv phages have been described (10, 17, 18, 27,
29, 30) (C. Freund, unpublished results).
fragment at
24 °C. The amount of soluble scFv fragment was >10-fold increased
in the presence of FkpA compared with its absence (Fig. 4a). The corresponding Western
blot shows a dramatic increase in soluble material if FkpA was
overexpressed. This antibody had been shown not to be amenable to rate
acceleration by PpiA2 or FkpA
(35) even though the proline cis,trans-isomerization is
rate-limiting (34).

View larger version (32K):
[in a new window]
Fig. 4.
Antigen-binding ELISA (a and
b) and Western blotting (c and
d) of crude extracts of E. coli JM83
expressing the soluble scFv fragments 4D5
(a and c) (31, 34) at 24 °C and
anti-GCN4 (H-R66K) (b and d) (33) at
37 °C with or without Skp and FkpA. i, insoluble
material; s, soluble material.

View larger version (31K):
[in a new window]
Fig. 5.
Antigen-binding ELISA (a)
and Western blotting (b) of crude extracts of E. coli JM83 expressing the soluble scFv fragment 4-4-20 (27)
with or without Skp, FkpA, PpiA, and SurA. FkpA' is missing the
last 123 amino acids of FkpA. i, insoluble material;
s, soluble material.
-D-thiogalactopyranoside. After expression at 24 °C overnight, all three coexpressed proteins could be detected by
Western blotting with the anti-His tag antibody and as additional bands
on SDS-polyacrylamide gel stained by Coomassie Blue (data not shown).
Also under these conditions, no improvement in the amount of soluble
scFv was obtained by the coexpression of PpiA and SurA (Fig.
6, c and d).
Expression experiments carried out at 37 °C showed the same results.
The improvement in periplasmic folding was caused only by FkpA and the
previously described Skp. Again, the results from the ELISA
experiments, measuring functional protein, were also reflected in the
amount of soluble protein (Fig. 6, a and b). It
can clearly be seen that only FkpA dramatically improved the amount of
scFv fragment 4-4-20, and it had the greatest effect on ABPC48-C(H22)S,
for which, however, also Skp was beneficial, and perhaps a very slight
effect of PpiA and SurA cannot be excluded.

View larger version (39K):
[in a new window]
Fig. 6.
Antigen-binding ELISA (a and
b) and Western blotting (c and
d) of crude extracts of E. coli JM83
expressing the soluble scFv fragments 4-4-20 (a and
c) (27) and ABPC48-C(H22)S (b and
d) (17, 18) with or without Skp, FkpA, PpiA, and SurA
at 37 °C. i, insoluble material; s, soluble
material.
-chain derived from the gene coding for variable region V
1. The mouse
locus contains three genes coding for variable regions
V
1, V
2, and V
X, of which
V
1 and V
2 are closely related, whereas
the V
X amino acid sequence is as divergent to other V
genes sequences as to V
gene sequences
(39). Antibodies derived from the V
1 gene, as is the
case for the anti-GCN4 scFv fragment, have been crystallized in at
least 22 independent crystal structures, and in no case has a
cis-proline been observed. Also, VH domains
never have cis-prolines, as found in 205 independent structures.3 Therefore, the
folding of this scFv fragment is not proline-limited.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
E-binding sites in the promoter region
(40). FkpA shows a high peptidyl cis,trans-isomerase
activity, as shown with RNase T1 as substrate (35).
light chains, which
normally contain two cis-prolines (positions L8 and L95),
has been investigated in detail (34, 36, 41, 42). The rate-limiting
step is the trans,cis-isomerization of the conserved Pro-L95
in the variable
domain, which is a necessary prerequisite for the
correct docking of VH. Human cyclophilin and E. coli PpiA have been shown to catalyze this reaction in vitro for the isolated VL domain and the Fv fragment
(where the domains are unlinked) (42), but inefficiently or even not at all for scFv fragments, probably because the domains are inaccessible in an early folding intermediate (36, 41, 42). The slow step of the
scFv fragment of the antibody hu4D5-8, with or without disulfides,
cannot be accelerated by PPIases (neither PpiA2 nor FkpA)
(35).
), and even more striking is
that its coexpression increases the yield of an scFv fragment lacking
cis-prolines. This suggests a folding assisting activity
that is independent of the PPIase activity. This result is supported by
the fact that neither PpiA nor SurA can replace FkpA in coexpression
experiments. Previous experiments (9) in which PpiA was overexpressed
together with the Fv, scFv, and Fab fragments of the antibody McPC603
also failed to show any significant effect for any of the fragments,
consistent with the results found here for PpiA with a different series
of scFv fragments.
-galactosidase, which is not affected by cyclosporin A, suggesting that its chaperone activity is not dependent on peptidyl
cis,trans-isomerase activity (47).
E activity (40). Together with the findings that high
level synthesis of FkpA can suppress the accumulation of unfolded
periplasmic and outer membrane proteins, it has been suggested that it
acts as a global folding catalyst (21). The expression of FkpA is increased by overproduction of
E and by creation of
extracytoplasmic stress; additionally,
E-binding sites
are found in its promoter region (40).
) whose rate-limiting step cannot be accelerated
by FkpA (35). These in vivo findings are directly reflected
in vitro, where the presence of FkpA during folding improves
the yield under conditions favoring aggregation, but does not
accelerate the slow step (35).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Ulrich Henning (Max-Planck-Institut for Biology, Tübingen, Germany) for the kind gift of bacterial strain RC354c and Kathrin Ramm, Sabine Jung, Jörg Burmester, Alain Tissot, and Jörg Willuda for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by Schweizerischer Nationalfonds Grants 31-46624.96 and 31-47302.96.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Genion Forschungsgesellschaft mbH, D-20149
Hamburg, Germany.
§ To whom correspondence should be addressed. Fax: 41-1-635-5712; E-mail: plueckthun@biocfebs.unizh.ch.
Published, JBC Papers in Press, March 22, 2000, DOI 10.1074/jbc.M910233199
2 M. Jäger and A. Plückthun, unpublished results.
3 A. Honegger, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: g3p, gene-3 protein; scFv, single-chain Fv; kb, kilobase pair(s); FITC, fluorescein isothiocyanate; ELISA, enzyme-linked immunosorbent assay; bp, base pair(s); PCR, polymerase chain reaction; PPIase, peptidylprolyl cis,trans-isomerase; FKBP, FK506-binding protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bardwell, J. C. (1994) Mol. Microbiol. 14, 199-205 |
| 2. | Rietsch, A., and Beckwith, J. (1998) Annu. Rev. Genet. 32, 163-184 |
| 3. | Plückthun, A., Krebber, A., Krebber, C., Horn, U., Knüpfer, R., Wenderoth, L., Nieba, L., Proba, K., and Riesanberg, D. (1996) Antibody Engineering: A Practical Approach , pp. 203-252, IRL Press Ltd., Oxford |
| 4. | Huston, J. S., McCartney, J., Tai, M. S., Mottola-Hartshorn, C., Jin, D., Warren, F., Keck, P., and Oppermann, H. (1993) Int. Rev. Immunol. 10, 195-217 |
| 5. | Dall'Acqua, W., and Carter, P. (1998) Curr. Opin. Struct. Biol. 8, 443-450 |
| 6. | Wall, J. G., and Plückthun, A. (1995) Curr. Opin. Biotechnol. 6, 507-516 |
| 7. | Danese, P. N., and Silhavy, T. J. (1998) Annu. Rev. Genet. 32, 59-94 |
| 8. | Skerra, A., and Plückthun, A. (1991) Protein Eng. 4, 971-979 |
| 9. | Knappik, A., Krebber, C., and Plückthun, A. (1993) Bio/Technology 11, 77-83 |
| 10. | Knappik, A., and Plückthun, A. (1995) Protein Eng. 8, 81-89 |
| 11. | Ulrich, H. D., Patten, P. A., Yang, P. L., Romesberg, F. E., and Schultz, P. G. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11907-11911 |
| 12. | Forsberg, G., Forsgren, M., Jaki, M., Norin, M., Sterky, C., Enhorning, A., Larsson, K., Ericsson, M., and Björk, P. (1997) J. Biol. Chem. 272, 12430-12436 |
| 13. | Suominen, I., Karp, M., Lahde, M., Kopio, A., Glumoff, T., Meyer, P., and Mantsala, P. (1987) Gene (Amst.) 61, 165-176 |
| 14. | Bothmann, H., and Plückthun, A. (1998) Nature Biotechnol. 16, 376-380 |
| 15. | Davis, N. G., Boeke, J. D., and Model, P. (1985) J. Mol. Biol. 181, 111-121 |
| 16. | Horne, S. M., and Young, K. D. (1995) Arch. Microbiol. 163, 357-365 |
| 17. | Proba, K., Honegger, A., and Plückthun, A. (1997) J. Mol. Biol. 265, 161-172 |
| 18. | Proba, K., Wörn, A., Honegger, A., and Plückthun, A. (1998) J. Mol. Biol. 275, 245-253 |
| 19. | Chen, R., and Henning, U. (1996) Mol. Microbiol. 19, 1287-1294 |
| 20. | Knappik, A., and Plückthun, A. (1994) BioTechniques 17, 754-761 |
| 21. | Missiakas, D., Betton, J. M., and Raina, S. (1996) Mol. Microbiol. 21, 871-884 |
| 22. | Wülfing, C., Lombardero, J., and Plückthun, A. (1994) J. Biol. Chem. 269, 2895-2901 |
| 23. | Roof, W. D., Horne, S. M., Young, K. D., and Young, R. (1994) J. Biol. Chem. 269, 2902-2910 |
| 24. | Roof, W. D., Fang, H. Q., Young, K. D., Sun, J., and Young, R. (1997) Mol. Microbiol. 25, 1031-1046 |
| 25. | Hottenrott, S., Schumann, T., Plückthun, A., Fischer, G., and Rahfeld, J.-U. (1997) J. Biol. Chem. 272, 15697-15701 |
| 26. | Bedzyk, W. D., Weidner, K. M., Denzin, L. K., Johnson, L. S., Hardman, K. D., Pantoliano, M. W., Asel, E. D., and Voss, E. W., Jr. (1990) J. Biol. Chem. 265, 18615-18620 |
| 27. | Nieba, L., Honegger, A., Krebber, C., and Plückthun, A. (1997) Protein Eng. 10, 435-444 |
| 28. | Jung, S., and Plückthun, A. (1997) Protein Eng. 10, 959-966 |
| 29. | Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., and Johnson, K. S. (1996) Nature Biotechnol. 14, 309-314 |
| 30. | Krebber, C., Spada, S., Desplancq, D., Krebber, A., Ge, L., and Plückthun, A. (1997) J. Mol. Biol. 268, 607-618 |
| 31. | Wörn, A., and Plückthun, A. (1998) FEBS Lett. 427, 357-361 |
| 32. | Hanes, J., Jermutus, L., Weber-Bornhauser, S., Bosshard, H. R., and Plückthun, A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14130-14135 |
| 33. | Wörn, A., Auf der Maur, A., Escher, D., Honegger, A., Barberis, A., and Plückthun, A. (2000) J. Biol. Chem. 275, 2795-2803 |
| 34. | Ramm, K., Gehrig, P., and Plückthun, A. (1999) J. Mol. Biol. 290, 535-546 |
| 35. | Ramm, K., and Plückthun, A. (2000) J. Biol. Chem. 275, 17106-17113 |
| 36. | Jäger, M., and Plückthun, A. (1999) J. Mol. Biol. 285, 2005-2019 |
| 37. | Tesar, M., Beckmann, C., Röttgen, P., Haase, B., Faude, U., and Timmis, K. N. (1995) Immunotechnology 1, 53-64 |
| 38. | Lindner, P., Bauer, K., Krebber, A., Nieba, L., Kremmer, E., Krebber, C., Honegger, A., Klinger, B., Mocikat, R., and Plückthun, A. (1997) BioTechniques 22, 140-149 |
| 39. | Sanchez, P., Marche, P. N., Rueff-Juy, D., and Cazenave, P. A. (1990) J. Immunol. 144, 2816-2820 |
| 40. | Danese, P. N., and Silhavy, T. J. (1997) Genes Dev. 11, 1183-1193 |
| 41. | Freund, C., Gehrig, P., Holak, T. A., and Plückthun, A. (1997) FEBS Lett. 407, 42-46 |
| 42. | Jäger, M., and Plückthun, A. (1997) FEBS Lett. 418, 106-110 |
| 43. | Freskgård, P. O., Bergenhem, N., Bengt-Harald, J., Svensson, M., and Carlsson, U. (1992) Science 258, 466-468 |
| 44. | Rinfret, A., Collins, C., Ménard, R., and Anderson, S. K. (1994) Biochemistry 33, 1668-1673 |
| 45. | Kern, G., Kern, D., Schmid, F. X., and Fischer, G. (1994) FEBS Lett. 348, 145-148 |
| 46. | Bose, S., Weikl, T., Bügl, H., and Buchner, J. (1996) Science 274, 1715-1717 |
| 47. | Freeman, B. C., Toft, D. O., and Morimoto, R. I. (1996) Science 274, 1718-1720 |
| 48. | Kleerebezem, M., Heutink, M., and Tommassen, J. (1995) Mol. Microbiol. 18, 313-320 |
| 49. | Dartigalongue, C., and Raina, S. (1998) EMBO J. 17, 3968-3980 |
| 50. | Lazar, S. W., and Kolter, R. (1996) J. Bacteriol. 178, 1770-1773 |
| 51. | Rouvière, P. E., and Gross, C. A. (1996) Genes Dev. 10, 3170-3182 |
| 52. | Rutherford, S. L., and Lindquist, S. (1998) Nature 396, 336-342 |
| 53. | Valent, Q. A., Kendall, D. A., High, S., Kusters, R., Oudega, B., and Luirink, J. (1995) EMBO J. 14, 5494-5505 |
| 54. | Callebaut, I., and Mormon, J. P. (1995) FEBS Lett. 374, 211-215 |
| 55. | Hesterkamp, T., Hauser, S., Lütcke, H., and Bukau, B. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4437-4441 |
| 56. | Mayer, M. P., and Bukau, B. (1999) Curr. Biol. 9, R322-R325 |
| 57. | Jayaraman, T., Brillantes, A. M., Timerman, A. P., Fleischer, S., Erdjument-Bromage, H., Tempst, P., and Marks, A. R. (1992) J. Biol. Chem. 267, 9474-9477 |
| 58. | Timerman, A. P., Ogunbumni, E., Freund, E., Wiederrecht, G., Marks, A. R., and Fleischer, S. (1993) J. Biol. Chem. 268, 22992-22999 |
| 59. | Brillantes, A. B., Ondrias, K., Scott, A., Kobrinsky, E., Ondriasova, E., Moschella, M. C., Jayaraman, T., Landers, M., Ehrlich, B. E., and Marks, A. R. (1994) Cell 77, 513-523 |
| 60. | Cameron, A. M., Steiner, J. P., Sabatini, D. M., Kaplin, A. I., Walensky, L. D., and Snyder, S. H. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1784-1788 |
| 61. | Melnick, J., and Argon, Y. (1995) Immunol. Today 16, 243-250 |
| 62. | Dolinski, K., Muir, S., Cardenas, M., and Heitman, J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13093-13098 |
| 63. | Rahfeld, J. U., Rücknagel, K. P., Schelbert, B., Ludwig, B., Hacker, J., Mann, K., and Fischer, G. (1994) FEBS Lett. 352, 180-184 |
| 64. | Hani, J., Stumpf, G., and Domdey, H. (1995) FEBS Lett. 365, 198-202 |
| 65. | Göthel, S. F., Scholz, C., Schmid, F. X., and Marahiel, M. A. (1998) Biochemistry 37, 13392-13399 |
| 66. | Pissavin, C., and Hugouvieux-Cotte-Pattat, N. (1997) FEMS Microbiol. Lett. 157, 59-65 |
This article has been cited by other articles:
![]() |
G.A. Loset, E. Lunde, B. Bogen, O.H. Brekke, and I. Sandlie Functional phage display of two murine {alpha}/{beta} T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance Protein Eng. Des. Sel., October 9, 2007; (2007) gzm044v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Sklar, T. Wu, D. Kahne, and T. J. Silhavy Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli Genes & Dev., October 1, 2007; 21(19): 2473 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schlapschy, S. Grimm, and A. Skerra A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli Protein Eng. Des. Sel., August 1, 2006; 19(8): 385 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mukherjee, D. C. D. Rowe, N. A. Watkins, and D. K. Summers Studies of Single-Chain Antibody Expression in Quiescent Escherichia coli Appl. Envir. Microbiol., May 1, 2004; 70(5): 3005 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Belin, J. Dassa, P. Drevet, E. Lajeunesse, A. Savatier, J.-C. Boulain, and A. Menez Toxicity-based selection of Escherichia coli mutants for functional recombinant protein production: application to an antibody fragment Protein Eng. Des. Sel., May 1, 2004; 17(5): 491 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Werner, A. M. Augustus, and R. Misra Assembly of TolC, a Structurally Unique and Multifunctional Outer Membrane Protein of Escherichia coli K-12 J. Bacteriol., November 15, 2003; 185(22): 6540 - 6547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atanassov, L. Pezennec, J. d'Alayer, G. Grollier, B. Picard, and J.-L. Fauchere Novel Antigens of Helicobacter pylori Correspond to Ulcer-Related Antibody Pattern of Sera from Infected Patients J. Clin. Microbiol., February 1, 2002; 40(2): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Webb, L. W. Ruddock, R. J. Marchant, K. Jonas, and P. Klappa Interaction of the Periplasmic Peptidylprolyl cis-trans Isomerase SurA with Model Peptides. THE N-TERMINAL REGION OF SurA IS ESSENTIAL AND SUFFICIENT FOR PEPTIDE BINDING J. Biol. Chem., November 30, 2001; 276(49): 45622 - 45627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Fernández, I. Sola, L. Enjuanes, and V. de Lorenzo Specific Secretion of Active Single-Chain Fv Antibodies into the Supernatants of Escherichia coli Cultures by Use of the Hemolysin System Appl. Envir. Microbiol., November 1, 2000; 66(11): 5024 - 5029. [Abstract] [Full Text] |
||||
![]() |
K. Ramm and A. Pluckthun The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA. II. ISOMERASE-INDEPENDENT CHAPERONE ACTIVITY IN VITRO J. Biol. Chem., May 26, 2000; 275(22): 17106 - 17113. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||